2 assets in Adnexal Spiradenoma/Cylindroma Of A Sweat Gland

Therapeutic assets addressing Adnexal Spiradenoma/Cylindroma Of A Sweat Gland, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
ICP34.5-, ICP47-DELETED HERPES SIMPLEX VIRUS 1 (HSV-1) INCORPORATING THE HUMAN GM-CSF GENE Adnexal Spiradenoma/Cylindroma Of A Sweat Gland	National Cancer Institute (NCI)	P2	CCC (53)
Nivolumab Adnexal Spiradenoma/Cylindroma Of A Sweat Gland	National Cancer Institute (NCI)	P2	CCC (53)